I am sure Dr Poon would have enough clout. He very well regarded. It’s just not our main focus at present. US and Europe is where it is at. Once we get CE mark, TGA should be relatively easy.
There are some processes we have to repeat for the FDA in order to start the Pivitol trial and so things just take time.
- Forums
- ASX - By Stock
- Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
AVR
anteris technologies global corp.
Add to My Watchlist
0.17%
!
$6.03

I am sure Dr Poon would have enough clout. He very well...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.03 |
Change
0.010(0.17%) |
Mkt cap ! $93.45M |
Open | High | Low | Value | Volume |
$6.00 | $6.16 | $5.80 | $52.24K | 8.792K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 857 | $5.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.45 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 857 | 5.830 |
1 | 900 | 5.780 |
1 | 450 | 5.750 |
1 | 1000 | 5.610 |
2 | 3500 | 5.600 |
Price($) | Vol. | No. |
---|---|---|
6.450 | 1000 | 1 |
6.550 | 1092 | 1 |
6.650 | 100 | 1 |
6.910 | 1000 | 1 |
7.010 | 1000 | 1 |
Last trade - 15.36pm 20/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |